Founded in 1991, Transgene Biotek Ltd was one of the first true Biotechnology companies in India, and is currently listed on the Bombay Stock Exchange (BSE: TRABI – 526139) and Luxembourg Stock Exchange. The company has an impressive product portfolio covering Oncology, Auto-Immunity, Drug Delivery and Biogenerics, and passionately strives to bring these technologies to commercialization in the least possible time. Transgene is committed to maximizing the potential of its pipeline, and bringing meaningful innovation to global health through strategic partnerships and collaborations.